Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia
NCT00492232
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
135
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Insomnia
Interventions
DRUG:
Ramelteon and zolpidem
DRUG:
Placebo and zolpidem
Sponsor
Takeda